|
WO2009132353A2
|
|
Differential diagnosis of prostate cancer and benign prostate disease
|
|
JP2007191490A
|
|
Extended type i chain glycosphingolipid as tumor-associated antigen
|
|
JP2006290824A
|
|
Use of trimethylsphingosine in ortho-signaling therapy during inflammation process
|
|
TWI265811B
|
|
Extended type 1 chain glycosphingolipids as tumor-associated antigens
|
|
AU2000260652B2
|
|
Extended type 1 chain glycosphingolipids as tumor-associated antigens
|
|
WO9804272A1
|
|
Chlamydia oligosaccharides
|
|
EP0765884A1
|
|
Anti-inflammatory compound
|
|
WO9634609A1
|
|
Myeloglycan
|
|
US5876715A
|
|
Antibodies that bind novel carbohydrate ligands (myelorollins) that cause E-selectin dependent cell rolling, and uses thereof
|
|
CA1339622C
|
|
Oncofetal fibronectin epitope
|
|
US5660834A
|
|
Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with carbohydrate-carrier conjugates
|
|
US5583160A
|
|
Methylsphingosine used to treat apoptosis
|
|
US5585473A
|
|
Compounds and methods for monosaccharide analysis
|
|
AU7472794A
|
|
N,N,N-trimethylsphingosine derivatives
|
|
US5466716A
|
|
Liposomal trimethylsphingosine
|
|
US6083929A
|
|
Extended type 1 chain glycosphingolipids as tumor-associated antigens
|
|
CA2136070A1
|
|
Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof
|
|
WO9323031A1
|
|
Multivalent mimetics and peptide mimetics for blocking carbohydrate-dependent cellular interaction and for eliciting anticarbohydrate t-cell response
|
|
EP0638085A1
|
|
Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto
|
|
US5374532A
|
|
Method for determining susceptibility to escherichia coli urinary tract infections and method for diagnosing secretors and nonsecretors
|
